PDS Biotechnology
(NASDAQ) PDSB
PDS Biotechnology Financials at a Glance
Market Cap
$51.80M
Revenue (TTM)
$0.00
Net Income (TTM)
$34.50M
EPS (TTM)
$-0.75
P/E Ratio
-1.24
Dividend
$0.00
Beta (Volatility)
1.99 (High)
Dividend
$0.00
Beta (Volatility)
1.99 (High)
Price
$0.90
Volume
921,474
Open
$0.93
Price
$0.90
Volume
921,474
Open
$0.93
Previous Close
$0.90
Daily Range
$0.86 - $0.99
52-Week Range
$0.51 - $1.92
Dividend
$0.00
Beta (Volatility)
1.99 (High)
Price
$0.90
Volume
921,474
Open
$0.93
Previous Close
$0.90
Daily Range
$0.86 - $0.99
52-Week Range
$0.51 - $1.92
PDSB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PDS Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Frank K. Bedu-Addo, PhD
Website
www.pdsbiotech.comHeadquarters
Princeton, NJ 07932, US
PDSB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-244%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-80.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$51.80M
Shares Outstanding
55.82M
Volume
921.47K
Short Interest
0.00%
Avg. Volume
738.27K
Financials (TTM)
Gross Profit
$60.52K
Operating Income
$31.54M
EBITDA
$30.30M
Operating Cash Flow
$27.75B
Capital Expenditure
$0.00
Free Cash Flow
$27.75B
Cash & ST Invst.
$26.71M
Total Debt
$5.19B
PDS Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$15.13K
-0.0%
Gross Margin
0.00%
N/A
Market Cap
$51.80M
N/A
Market Cap/Employee
$2.16M
N/A
Employees
24
N/A
Net Income
$7.56M
+4.9%
EBITDA
$6.44M
+5.8%
Quarterly Fundamentals
Net Cash
$5.17B
-26107.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$11.76M
+26.9%
Short Term Debt
$5.17B
+41031.2%
Return on Assets
-1.13%
N/A
Return on Invested Capital
-1.50%
N/A
Free Cash Flow
$3.70M
+55.0%
Operating Cash Flow
$3.70M
+55.0%